 | • レポートコード：QYR2104Z0315 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、退形成性星細胞腫のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（テモダール、テモゾロミド、マチュラン、プロカルバジン、その他）、用途別市場規模（事前登録フェーズ、臨床試験フェーズ）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・退形成性星細胞腫の市場動向 ・企業の競争状況、市場シェア ・退形成性星細胞腫の種類別市場規模（テモダール、テモゾロミド、マチュラン、プロカルバジン、その他） ・退形成性星細胞腫の用途別市場規模（事前登録フェーズ、臨床試験フェーズ） ・退形成性星細胞腫の北米市場規模2016-2027（アメリカ、カナダ） ・退形成性星細胞腫のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・退形成性星細胞腫のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・退形成性星細胞腫の中南米市場規模2016-2027（メキシコ、ブラジル） ・退形成性星細胞腫の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Genentech、Isarna Therapeutics、Axelar、Pfizer、Amgen、Novartis、Avid Bioservices、EirGen Pharma、Boehringer Ingelheim、Celldex Therapeutics） ・結論 |
Anaplastic astrocytoma is a rare malignant brain tumor.
Globally, North America contributed the highest revenues in anaplastic astrocytoma market due to deep reach of the treatments to the large number of population followed by Europe and Asia-Pacific regions as the second and third largest markets for Anaplastic astrocytoma.
Market Analysis and Insights: Global Anaplastic Astrocytoma Market
The global Anaplastic Astrocytoma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anaplastic Astrocytoma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anaplastic Astrocytoma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anaplastic Astrocytoma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anaplastic Astrocytoma market.
Global Anaplastic Astrocytoma Scope and Market Size
Anaplastic Astrocytoma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anaplastic Astrocytoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Temodar
Temozolomide
Matulane
Procarbazine
Others
Segment by Application
Pre-Registration Phase
Clinical Trail Phase
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Genentech
Isarna Therapeutics
Axelar
Pfizer
Amgen
Novartis
Avid Bioservices
EirGen Pharma
Boehringer Ingelheim
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anaplastic Astrocytoma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Temodar
1.2.3 Temozolomide
1.2.4 Matulane
1.2.5 Procarbazine
1.2.6 Others
1.3 Market by Application
1.3.1 Global Anaplastic Astrocytoma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pre-Registration Phase
1.3.3 Clinical Trail Phase
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anaplastic Astrocytoma Market Perspective (2016-2027)
2.2 Anaplastic Astrocytoma Growth Trends by Regions
2.2.1 Anaplastic Astrocytoma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anaplastic Astrocytoma Historic Market Share by Regions (2016-2021)
2.2.3 Anaplastic Astrocytoma Forecasted Market Size by Regions (2022-2027)
2.3 Anaplastic Astrocytoma Industry Dynamic
2.3.1 Anaplastic Astrocytoma Market Trends
2.3.2 Anaplastic Astrocytoma Market Drivers
2.3.3 Anaplastic Astrocytoma Market Challenges
2.3.4 Anaplastic Astrocytoma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anaplastic Astrocytoma Players by Revenue
3.1.1 Global Top Anaplastic Astrocytoma Players by Revenue (2016-2021)
3.1.2 Global Anaplastic Astrocytoma Revenue Market Share by Players (2016-2021)
3.2 Global Anaplastic Astrocytoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anaplastic Astrocytoma Revenue
3.4 Global Anaplastic Astrocytoma Market Concentration Ratio
3.4.1 Global Anaplastic Astrocytoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anaplastic Astrocytoma Revenue in 2020
3.5 Anaplastic Astrocytoma Key Players Head office and Area Served
3.6 Key Players Anaplastic Astrocytoma Product Solution and Service
3.7 Date of Enter into Anaplastic Astrocytoma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anaplastic Astrocytoma Breakdown Data by Type
4.1 Global Anaplastic Astrocytoma Historic Market Size by Type (2016-2021)
4.2 Global Anaplastic Astrocytoma Forecasted Market Size by Type (2022-2027)
5 Anaplastic Astrocytoma Breakdown Data by Application
5.1 Global Anaplastic Astrocytoma Historic Market Size by Application (2016-2021)
5.2 Global Anaplastic Astrocytoma Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anaplastic Astrocytoma Market Size (2016-2027)
6.2 North America Anaplastic Astrocytoma Market Size by Type
6.2.1 North America Anaplastic Astrocytoma Market Size by Type (2016-2021)
6.2.2 North America Anaplastic Astrocytoma Market Size by Type (2022-2027)
6.2.3 North America Anaplastic Astrocytoma Market Size by Type (2016-2027)
6.3 North America Anaplastic Astrocytoma Market Size by Application
6.3.1 North America Anaplastic Astrocytoma Market Size by Application (2016-2021)
6.3.2 North America Anaplastic Astrocytoma Market Size by Application (2022-2027)
6.3.3 North America Anaplastic Astrocytoma Market Size by Application (2016-2027)
6.4 North America Anaplastic Astrocytoma Market Size by Country
6.4.1 North America Anaplastic Astrocytoma Market Size by Country (2016-2021)
6.4.2 North America Anaplastic Astrocytoma Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anaplastic Astrocytoma Market Size (2016-2027)
7.2 Europe Anaplastic Astrocytoma Market Size by Type
7.2.1 Europe Anaplastic Astrocytoma Market Size by Type (2016-2021)
7.2.2 Europe Anaplastic Astrocytoma Market Size by Type (2022-2027)
7.2.3 Europe Anaplastic Astrocytoma Market Size by Type (2016-2027)
7.3 Europe Anaplastic Astrocytoma Market Size by Application
7.3.1 Europe Anaplastic Astrocytoma Market Size by Application (2016-2021)
7.3.2 Europe Anaplastic Astrocytoma Market Size by Application (2022-2027)
7.3.3 Europe Anaplastic Astrocytoma Market Size by Application (2016-2027)
7.4 Europe Anaplastic Astrocytoma Market Size by Country
7.4.1 Europe Anaplastic Astrocytoma Market Size by Country (2016-2021)
7.4.2 Europe Anaplastic Astrocytoma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anaplastic Astrocytoma Market Size (2016-2027)
8.2 Asia-Pacific Anaplastic Astrocytoma Market Size by Type
8.2.1 Asia-Pacific Anaplastic Astrocytoma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anaplastic Astrocytoma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anaplastic Astrocytoma Market Size by Type (2016-2027)
8.3 Asia-Pacific Anaplastic Astrocytoma Market Size by Application
8.3.1 Asia-Pacific Anaplastic Astrocytoma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anaplastic Astrocytoma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anaplastic Astrocytoma Market Size by Application (2016-2027)
8.4 Asia-Pacific Anaplastic Astrocytoma Market Size by Region
8.4.1 Asia-Pacific Anaplastic Astrocytoma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anaplastic Astrocytoma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anaplastic Astrocytoma Market Size (2016-2027)
9.2 Latin America Anaplastic Astrocytoma Market Size by Type
9.2.1 Latin America Anaplastic Astrocytoma Market Size by Type (2016-2021)
9.2.2 Latin America Anaplastic Astrocytoma Market Size by Type (2022-2027)
9.2.3 Latin America Anaplastic Astrocytoma Market Size by Type (2016-2027)
9.3 Latin America Anaplastic Astrocytoma Market Size by Application
9.3.1 Latin America Anaplastic Astrocytoma Market Size by Application (2016-2021)
9.3.2 Latin America Anaplastic Astrocytoma Market Size by Application (2022-2027)
9.3.3 Latin America Anaplastic Astrocytoma Market Size by Application (2016-2027)
9.4 Latin America Anaplastic Astrocytoma Market Size by Country
9.4.1 Latin America Anaplastic Astrocytoma Market Size by Country (2016-2021)
9.4.2 Latin America Anaplastic Astrocytoma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anaplastic Astrocytoma Market Size (2016-2027)
10.2 Middle East & Africa Anaplastic Astrocytoma Market Size by Type
10.2.1 Middle East & Africa Anaplastic Astrocytoma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anaplastic Astrocytoma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anaplastic Astrocytoma Market Size by Type (2016-2027)
10.3 Middle East & Africa Anaplastic Astrocytoma Market Size by Application
10.3.1 Middle East & Africa Anaplastic Astrocytoma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anaplastic Astrocytoma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anaplastic Astrocytoma Market Size by Application (2016-2027)
10.4 Middle East & Africa Anaplastic Astrocytoma Market Size by Country
10.4.1 Middle East & Africa Anaplastic Astrocytoma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anaplastic Astrocytoma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Genentech
11.1.1 Genentech Company Details
11.1.2 Genentech Business Overview
11.1.3 Genentech Anaplastic Astrocytoma Introduction
11.1.4 Genentech Revenue in Anaplastic Astrocytoma Business (2016-2021)
11.1.5 Genentech Recent Development
11.2 Isarna Therapeutics
11.2.1 Isarna Therapeutics Company Details
11.2.2 Isarna Therapeutics Business Overview
11.2.3 Isarna Therapeutics Anaplastic Astrocytoma Introduction
11.2.4 Isarna Therapeutics Revenue in Anaplastic Astrocytoma Business (2016-2021)
11.2.5 Isarna Therapeutics Recent Development
11.3 Axelar
11.3.1 Axelar Company Details
11.3.2 Axelar Business Overview
11.3.3 Axelar Anaplastic Astrocytoma Introduction
11.3.4 Axelar Revenue in Anaplastic Astrocytoma Business (2016-2021)
11.3.5 Axelar Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Anaplastic Astrocytoma Introduction
11.4.4 Pfizer Revenue in Anaplastic Astrocytoma Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Anaplastic Astrocytoma Introduction
11.5.4 Amgen Revenue in Anaplastic Astrocytoma Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anaplastic Astrocytoma Introduction
11.6.4 Novartis Revenue in Anaplastic Astrocytoma Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Avid Bioservices
11.7.1 Avid Bioservices Company Details
11.7.2 Avid Bioservices Business Overview
11.7.3 Avid Bioservices Anaplastic Astrocytoma Introduction
11.7.4 Avid Bioservices Revenue in Anaplastic Astrocytoma Business (2016-2021)
11.7.5 Avid Bioservices Recent Development
11.8 EirGen Pharma
11.8.1 EirGen Pharma Company Details
11.8.2 EirGen Pharma Business Overview
11.8.3 EirGen Pharma Anaplastic Astrocytoma Introduction
11.8.4 EirGen Pharma Revenue in Anaplastic Astrocytoma Business (2016-2021)
11.8.5 EirGen Pharma Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Anaplastic Astrocytoma Introduction
11.9.4 Boehringer Ingelheim Revenue in Anaplastic Astrocytoma Business (2016-2021)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Celldex Therapeutics
11.10.1 Celldex Therapeutics Company Details
11.10.2 Celldex Therapeutics Business Overview
11.10.3 Celldex Therapeutics Anaplastic Astrocytoma Introduction
11.10.4 Celldex Therapeutics Revenue in Anaplastic Astrocytoma Business (2016-2021)
11.10.5 Celldex Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anaplastic Astrocytoma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Temodar
Table 3. Key Players of Temozolomide
Table 4. Key Players of Matulane
Table 5. Key Players of Procarbazine
Table 6. Key Players of Others
Table 7. Global Anaplastic Astrocytoma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Anaplastic Astrocytoma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Anaplastic Astrocytoma Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Anaplastic Astrocytoma Market Share by Regions (2016-2021)
Table 11. Global Anaplastic Astrocytoma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Anaplastic Astrocytoma Market Share by Regions (2022-2027)
Table 13. Anaplastic Astrocytoma Market Trends
Table 14. Anaplastic Astrocytoma Market Drivers
Table 15. Anaplastic Astrocytoma Market Challenges
Table 16. Anaplastic Astrocytoma Market Restraints
Table 17. Global Anaplastic Astrocytoma Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Anaplastic Astrocytoma Market Share by Players (2016-2021)
Table 19. Global Top Anaplastic Astrocytoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anaplastic Astrocytoma as of 2020)
Table 20. Ranking of Global Top Anaplastic Astrocytoma Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Anaplastic Astrocytoma Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Anaplastic Astrocytoma Product Solution and Service
Table 24. Date of Enter into Anaplastic Astrocytoma Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anaplastic Astrocytoma Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Anaplastic Astrocytoma Revenue Market Share by Type (2016-2021)
Table 28. Global Anaplastic Astrocytoma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Anaplastic Astrocytoma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Anaplastic Astrocytoma Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Anaplastic Astrocytoma Revenue Market Share by Application (2016-2021)
Table 32. Global Anaplastic Astrocytoma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Anaplastic Astrocytoma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Anaplastic Astrocytoma Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Anaplastic Astrocytoma Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Anaplastic Astrocytoma Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Anaplastic Astrocytoma Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Anaplastic Astrocytoma Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Anaplastic Astrocytoma Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Anaplastic Astrocytoma Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Anaplastic Astrocytoma Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Anaplastic Astrocytoma Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Anaplastic Astrocytoma Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Anaplastic Astrocytoma Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Anaplastic Astrocytoma Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anaplastic Astrocytoma Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anaplastic Astrocytoma Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anaplastic Astrocytoma Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Anaplastic Astrocytoma Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Anaplastic Astrocytoma Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Anaplastic Astrocytoma Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Anaplastic Astrocytoma Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Anaplastic Astrocytoma Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Anaplastic Astrocytoma Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Anaplastic Astrocytoma Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Anaplastic Astrocytoma Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Anaplastic Astrocytoma Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anaplastic Astrocytoma Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anaplastic Astrocytoma Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anaplastic Astrocytoma Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Anaplastic Astrocytoma Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Anaplastic Astrocytoma Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Anaplastic Astrocytoma Market Size by Country (2022-2027) & (US$ Million)
Table 64. Genentech Company Details
Table 65. Genentech Business Overview
Table 66. Genentech Anaplastic Astrocytoma Product
Table 67. Genentech Revenue in Anaplastic Astrocytoma Business (2016-2021) & (US$ Million)
Table 68. Genentech Recent Development
Table 69. Isarna Therapeutics Company Details
Table 70. Isarna Therapeutics Business Overview
Table 71. Isarna Therapeutics Anaplastic Astrocytoma Product
Table 72. Isarna Therapeutics Revenue in Anaplastic Astrocytoma Business (2016-2021) & (US$ Million)
Table 73. Isarna Therapeutics Recent Development
Table 74. Axelar Company Details
Table 75. Axelar Business Overview
Table 76. Axelar Anaplastic Astrocytoma Product
Table 77. Axelar Revenue in Anaplastic Astrocytoma Business (2016-2021) & (US$ Million)
Table 78. Axelar Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Anaplastic Astrocytoma Product
Table 82. Pfizer Revenue in Anaplastic Astrocytoma Business (2016-2021) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. Amgen Company Details
Table 85. Amgen Business Overview
Table 86. Amgen Anaplastic Astrocytoma Product
Table 87. Amgen Revenue in Anaplastic Astrocytoma Business (2016-2021) & (US$ Million)
Table 88. Amgen Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Anaplastic Astrocytoma Product
Table 92. Novartis Revenue in Anaplastic Astrocytoma Business (2016-2021) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Avid Bioservices Company Details
Table 95. Avid Bioservices Business Overview
Table 96. Avid Bioservices Anaplastic Astrocytoma Product
Table 97. Avid Bioservices Revenue in Anaplastic Astrocytoma Business (2016-2021) & (US$ Million)
Table 98. Avid Bioservices Recent Development
Table 99. EirGen Pharma Company Details
Table 100. EirGen Pharma Business Overview
Table 101. EirGen Pharma Revenue in Anaplastic Astrocytoma Business (2016-2021) & (US$ Million)
Table 102. EirGen Pharma Recent Development
Table 103. Boehringer Ingelheim Company Details
Table 104. Boehringer Ingelheim Business Overview
Table 105. Boehringer Ingelheim Anaplastic Astrocytoma Product
Table 106. Boehringer Ingelheim Revenue in Anaplastic Astrocytoma Business (2016-2021) & (US$ Million)
Table 107. Boehringer Ingelheim Recent Development
Table 108. Celldex Therapeutics Company Details
Table 109. Celldex Therapeutics Business Overview
Table 110. Celldex Therapeutics Anaplastic Astrocytoma Product
Table 111. Celldex Therapeutics Revenue in Anaplastic Astrocytoma Business (2016-2021) & (US$ Million)
Table 112. Celldex Therapeutics Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anaplastic Astrocytoma Market Share by Type: 2020 VS 2027
Figure 2. Temodar Features
Figure 3. Temozolomide Features
Figure 4. Matulane Features
Figure 5. Procarbazine Features
Figure 6. Others Features
Figure 7. Global Anaplastic Astrocytoma Market Share by Application: 2020 VS 2027
Figure 8. Pre-Registration Phase Case Studies
Figure 9. Clinical Trail Phase Case Studies
Figure 10. Anaplastic Astrocytoma Report Years Considered
Figure 11. Global Anaplastic Astrocytoma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Anaplastic Astrocytoma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anaplastic Astrocytoma Market Share by Regions: 2020 VS 2027
Figure 14. Global Anaplastic Astrocytoma Market Share by Regions (2022-2027)
Figure 15. Global Anaplastic Astrocytoma Market Share by Players in 2020
Figure 16. Global Top Anaplastic Astrocytoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anaplastic Astrocytoma as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Anaplastic Astrocytoma Revenue in 2020
Figure 18. Global Anaplastic Astrocytoma Revenue Market Share by Type (2016-2021)
Figure 19. Global Anaplastic Astrocytoma Revenue Market Share by Type (2022-2027)
Figure 20. North America Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Anaplastic Astrocytoma Market Share by Type (2016-2027)
Figure 22. North America Anaplastic Astrocytoma Market Share by Application (2016-2027)
Figure 23. North America Anaplastic Astrocytoma Market Share by Country (2016-2027)
Figure 24. United States Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Anaplastic Astrocytoma Market Share by Type (2016-2027)
Figure 28. Europe Anaplastic Astrocytoma Market Share by Application (2016-2027)
Figure 29. Europe Anaplastic Astrocytoma Market Share by Country (2016-2027)
Figure 30. Germany Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Anaplastic Astrocytoma Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Anaplastic Astrocytoma Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Anaplastic Astrocytoma Market Share by Region (2016-2027)
Figure 40. China Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Anaplastic Astrocytoma Market Share by Type (2016-2027)
Figure 48. Latin America Anaplastic Astrocytoma Market Share by Application (2016-2027)
Figure 49. Latin America Anaplastic Astrocytoma Market Share by Country (2016-2027)
Figure 50. Mexico Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Anaplastic Astrocytoma Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Anaplastic Astrocytoma Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Anaplastic Astrocytoma Market Share by Country (2016-2027)
Figure 56. Turkey Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Anaplastic Astrocytoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Genentech Revenue Growth Rate in Anaplastic Astrocytoma Business (2016-2021)
Figure 60. Isarna Therapeutics Revenue Growth Rate in Anaplastic Astrocytoma Business (2016-2021)
Figure 61. Axelar Revenue Growth Rate in Anaplastic Astrocytoma Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Anaplastic Astrocytoma Business (2016-2021)
Figure 63. Amgen Revenue Growth Rate in Anaplastic Astrocytoma Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Anaplastic Astrocytoma Business (2016-2021)
Figure 65. Avid Bioservices Revenue Growth Rate in Anaplastic Astrocytoma Business (2016-2021)
Figure 66. EirGen Pharma Revenue Growth Rate in Anaplastic Astrocytoma Business (2016-2021)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in Anaplastic Astrocytoma Business (2016-2021)
Figure 68. Celldex Therapeutics Revenue Growth Rate in Anaplastic Astrocytoma Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed